Vinblastine Sulfate

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Nov 25, 1965	VelbanNDA 12665 · New molecular entity	Lilly	34	Discontinued
Apr 9, 1987	Vinblastine SulfateANDA 89395	Hikma	9	Marketed
Apr 29, 1987	Vinblastine SulfateANDA 89515	Fresenius Kabi USA	16	Marketed
Aug 18, 1987	Vinblastine SulfateANDA 89565	Hospira	19	Discontinued
—	Vinblastine SulfateANDA 89011	Abraxis Pharm	0	Discontinued
—	Vinblastine SulfateANDA 89311	Quad Pharms	0	Discontinued
—	Vinblastine SulfateANDA 89365	Quad Pharms	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA